Histopathological and clinical changes in patients with severe lupus nephritis treated with rituximab plus cyclophosphamide: A rebiopsy study in 7 patients

被引:0
|
作者
Gunnarsson, I.
Sundelin, B.
Jonsdottir, T.
Jacobsson, S. H.
Welin-Henriksson, E.
Van Vollenhoven, R. F.
机构
[1] Karolinska Univ Hosp, Stockholm, Sweden
[2] Danderyd Hosp, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:64 / 64
页数:1
相关论文
共 50 条
  • [41] Absolute Monocyte Count in Follicular Lymphoma Patients Treated with Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
    Watanabe, Reina
    Tomita, Naoto
    Kishimoto, Kumiko
    Koyama, Satoshi
    Ogusa, Eriko
    Ishii, Yoshimi
    Miyashita, Kazuho
    Matsuura, Shiro
    Fujisawa, Shin
    Hattori, Yukako
    Takasaki, Hirotaka
    Fujita, Atsuko
    Ohshima, Rika
    Kuwabara, Hideyuki
    Hashimoto, Chizuko
    Fujimaki, Katsumichi
    Sakai, Rika
    Ishigatsubo, Yoshiaki
    BLOOD, 2012, 120 (21)
  • [42] Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone
    Watanabe, Reina
    Tomita, Naoto
    Kishimoto, Kumiko
    Koyama, Satoshi
    Ogusa, Eriko
    Ishii, Yoshimi
    Miyashita, Kazuho
    Matsuura, Shiro
    Fujisawa, Shin
    Hattori, Yukako
    Takasaki, Hirotaka
    Fujita, Atsuko
    Ohshima, Rika
    Kuwabara, Hideyuki
    Hashimoto, Chizuko
    Fujimaki, Katsumichi
    Sakai, Rika
    Ishigatsubo, Yoshiaki
    LEUKEMIA RESEARCH, 2013, 37 (10) : 1208 - 1212
  • [43] Changes In Apoptotic Gene Expression Profile In CLL Patients Treated with Cladribine, Cyclophosphamide and Rituximab (CCR)
    Franiak-Pietryga, Ida
    Salagacka, Aleksandra
    Maciejewski, Henryk
    Blonski, Jerzy Z.
    Kotkowska, Aleksandra
    Mirowski, Marek
    Robak, Tadeusz
    Korycka-Wolowiec, Anna
    BLOOD, 2010, 116 (21) : 1025 - 1026
  • [44] PHENOTYPIC CHANGES OF LYMPHOCYTES IN PATIENTS WITH SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH AN INTENSIFIED B-CELL DEPLETION THERAPY WITH RITUXIMAB
    Sciascia, S.
    Baldovino, S.
    Menegatti, E.
    Solfietti, L.
    Di Simone, D.
    Rossi, D.
    Roccatello, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 560 - 560
  • [45] PREDICTIVE VALUE OF RENAL BIOPSY IN PATIENTS WITH FOCAL AND DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS (LN) TREATED WITH INTRAVENOUS CYCLOPHOSPHAMIDE
    CONLON, PJ
    FISHER, C
    LEVESQUE, M
    STCLAIR, EW
    ALLEN, N
    SMITH, SR
    HOWELL, DN
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 415 - 415
  • [46] Pregnancy outcomes and the risk for ovarian failure in patients with lupus nephritis treated by intravenous cyclophosphamide pulse therapy.
    Park, MC
    Jung, SY
    Kim, DY
    Chung, IH
    Park, YB
    Lee, SK
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S179 - S179
  • [47] LONG-TERM EVOLUTION OF DIFFUSE PROLIFERATIVE LUPUS NEPHRITIS - RETROSPECTIVE STUDY OF 32 PATIENTS TREATED WITH CORTICOSTEROIDS OR COMBINED CORTICOSTEROIDS AND CYCLOPHOSPHAMIDE
    JUNGERS, P
    DOUGADOS, M
    TRON, F
    LEIBOWITCH, J
    LESAVRE, P
    DROZ, D
    BACH, JF
    KIDNEY INTERNATIONAL, 1980, 17 (05) : 703 - 703
  • [49] Efficacy of methylprednisolone and urokinase pulse therapy combined with or without cyclophosphamide in severe Henoch-Schoenlein nephritis: a clinical and histopathological study
    Kawasaki, Y
    Suzuki, J
    Suzuki, H
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (04) : 858 - 864
  • [50] Risk Factors for Severe Infections in Rituximab Treated Patients: Comparison of Systemic Lupus Erythematosus and Inflammatory Myositis
    Medeiros, Cristiane
    Seguro, Luciana
    Carlos de Souza, Fernando Henrique
    Aikawa, Nadia E.
    Bonfa, Eloisa
    ARTHRITIS & RHEUMATOLOGY, 2016, 68